Transferases TRIZ Cases

Extending the 5' non-coding sequence upstream of the T7 promoter prevents dsRNA formation, eliminating immune response stimulation without lowering RNA yields.

Silencing the beta-1,2-xylosyltransferase gene in Nicotiana benthamiana eliminates immunogenic xylose residues from therapeutic proteins.

Leucine-to-basic-amino-acid mutation in 2-O-sulfation enzyme resolves low activity bottleneck, enabling efficient heparin manufacturing.

Engineered PglB enzymes replace chemical coupling steps, streamlining glycoconjugate production and enhancing vaccine immunogenicity.

Specific amino acid substitutions in the AHAS enzyme enable sunflower tolerance to multiple herbicide families, resolving yield loss from weed competition.

ARS ribozyme attaches unnatural amino acids to initiator tRNA, enabling biosynthetic synthesis of unique N-terminal structures.

Deleting error-prone DNA polymerases in reduced genome bacteria lowers spontaneous mutation rates, resolving genetic instability during toxic gene expression.

Replacing optical sensors with ISFETs and synthesizing proteins in situ stabilizes arrays while enabling high-throughput kinase activity analysis.

Recombinase activation of endogenous genes separates treatment efficacy from disease reversibility, defining optimal therapeutic timeframes.

Supercomputing-assisted mutations extend the half-life of D-amino acid transaminase to over 12 hours at 40°C, overcoming rapid wild-type denaturation.

Recombinant testosteronan synthase produces a novel heparosan analog, avoiding complex animal-derived production and supply chain risks.

Segmenting large mirror-image proteins into smaller units resolves synthesis efficiency bottlenecks while maintaining functional activity.

Engineered microbial platforms replace complex chemical synthesis with enzymatic pathways for efficient 6′sialyllactose production.

Enzymatic sulfation using C4ST or C6ST replaces complex chemical synthesis, avoiding keratan sulfate contamination and bovine safety risks.

Inducible XIST transgene coats chromosome 21 to trigger heterochromatin formation and transcriptional silencing.

Engineered IRX10 polypeptides compete with native enzymes to reduce xylan polymer synthesis in plant biomass.

Engineered polymerase synthesizes modified RNA oligomers through template-directed enzymatic incorporation, overcoming solid-phase synthesis length limits.

Segmented enzymatic pathways in recombinant hosts resolve low yield and industrial scalability bottlenecks for methylated cinnamic acid production.

Deleting the FAE1 gene in recombinant camelina reduces gamma-linolenic acid accumulation while increasing eicosapentaenoic acid and docosahexaenoic acid yields.

Local quality principles guide asymmetric modification patterns that resolve the trade-off between nuclease resistance and cellular uptake efficiency.

Segmented fluorescent tags resolve background interference during cell-free synthesis detection.

Engineered polymerases synthesize orthogonal nucleic acid polymers like HNA and CeNA through targeted thumb region mutations.

Genetic modification of key enzymes increases mycosporine-like amino acid yields, resolving low productivity constraints in biosynthetic pathways.

Reducing ferulic acid via acyltransferase modulation increases soluble sugar yields and enhances biofuel production potential from biomass.

Engineering Cre recombinase into a heterotetramer with distinct subunits enables recombination at arbitrary asymmetric sites while reducing off-target effects.

Lipid acyltransferase converts phospholipids to cholesterol esters, reducing cholesterol without expensive protein emulsifiers.

Site-directed mutagenesis at positions L195P and S247G in plant EPSPS yields glyphosate resistance without exogenous genes, resolving public acceptance issues.

Transgenic bacteria express phenylpyruvate decarboxylase to synthesize tyrosol, replacing low-yield plant extraction with high-efficiency fermentation.

Replacing detergents with free arginine and cryoprotectants prevents protein denaturation, extending polymerase shelf-life nine-fold.

Non-functional mutant polymerase proteins stabilize active enzymes, eliminating detergent interference with downstream applications.

Engineered T7 RNA polymerase variants selectively incorporate m7G cap analogs over GTP, reducing required concentrations and lowering production costs.

Codon-optimized AAV vectors restore PGM1 enzyme activity in cardiac tissue, halting dilated cardiomyopathy progression caused by genetic deficiency.

Chimeric archaeal polymerases combine reverse transcription and error correction capabilities to resolve fidelity limitations in long RNA template sequencing.

Introducing a foreign metZ gene into Corynebacterium enables direct sulfhydration of acylhomoserine for high-yield L-methionine synthesis.

Site-directed nucleotide substitution modifies the EPSPS protein in rice to confer glyphosate resistance, eliminating yield loss from weed competition.

Targeted amino acid substitutions in mutant DNA ligases enable efficient end-joining activity under high temperature and high salt conditions.

Recombinant AAV vectors deliver DN-DLK inhibitors driven by rhodopsin promoters to treat optic neuropathies while minimizing off-target effects.

Specialized TdT variants overcome reduced incorporation rates of blocked nucleotides and secondary structures in template-free synthesis.

Enzymatic conversion of fructose to tagatose overcomes lactose supply instability.

Disrupting pyruvate decarboxylase activity redirects carbon flux toward 2,3-butanediol synthesis, resolving low yield trade-offs in wild yeast fermentation.

Point mutations in O-methyltransferase shift methylation selectivity toward meta-position, eliminating iso-vanillin side products.

Extracting internal domains from piggyBac vectors eliminates insertional mutagenesis risk while maintaining high transposition efficiency.

A multi-step enzymatic process converts ADP to ATP using sucrose synthase and pyrophosphorylase in aqueous solution.

Engineered DNA viruses deliver error-prone polymerases to metazoan cells, bypassing slow discrete screening steps to enable continuous directed evolution.

Engineered recombinant host microorganisms produce hydroxytyrosol via decarboxylase and hydroxylase enzymes, eliminating L-DOPA side products.

A synthetic enzymatic cascade produces adenosine triphosphate from ADP using inexpensive fuel sources.

Glucan dikinase phosphorylates starch residues to enable amylase degradation without harsh chemicals.

Segmented enzymatic conversion of benzaldehyde achieves high enantiomeric purity while reducing process complexity.